⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

LRMR News

Larimar Therapeutics, Inc. Common Stock

Larimar Therapeutics Announces Conference Call on the Nomlabofusp Program for the Treatment of Friedreich’s Ataxia